Literature DB >> 1557959

Immunohistochemical study of a case with progressive supranuclear palsy without ophthalmoplegia.

E Kida1, M Barcikowska, M Niemczewska.   

Abstract

A case of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome; PSP) with parkinsonism and absence of gaze palsy or mental changes is reported. Neuropathological examination, apart from typical changes, showed, lack of midbrain tegmentum demyelination, marked loss of Purkinje cells and presence of hyalin-like bodies in individual neurons of the substantia nigra. Immunostaining against tau-1 protein revealed the prevalence of a diffuse reaction in locus coeruleus neurons; reflecting either different ability of these cells to accumulate straight filaments, or a various time sequence of neurofibrillary tangles formation. Ferritin immunohistochemistry demonstrated widespread microglial cell proliferation, confirming further the generalized character of CNS pathology in PSP.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1557959     DOI: 10.1007/bf00296797

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  30 in total

1.  PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

Authors:  J C STEELE; J C RICHARDSON; J OLSZEWSKI
Journal:  Arch Neurol       Date:  1964-04

Review 2.  Corticonigral degeneration with neuronal achromasia and basal neurofibrillary tangles.

Authors:  W Paulus; M Selim
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

3.  Neurofibrillary tangles in Alzheimer's disease and progressive supranuclear palsy: antigenic similarities and differences. Microtubule-associated protein tau antigenicity is prominent in all types of tangles.

Authors:  C Bancher; H Lassmann; H Budka; I Grundke-Iqbal; K Iqbal; G Wiche; F Seitelberger; H M Wisniewski
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

4.  Ultrastructure of neurofibrillary tangles in Steele-Richardson-Olszewski syndrome.

Authors:  I Tellez-Nagel; H M Wiśniewski
Journal:  Arch Neurol       Date:  1973-11

5.  New aspects of the pathology of neurodegenerative disorders as revealed by ubiquitin antibodies.

Authors:  P N Leigh; A Probst; G E Dale; D P Power; J P Brion; A Dodson; B H Anderton
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

6.  [Steele-Richardson-Olszewski disease without ophthalmoplegia. 6 clinico-anatomic cases].

Authors:  F Dubas; F Gray; R Escourolle
Journal:  Rev Neurol (Paris)       Date:  1983       Impact factor: 2.607

7.  Progressive supranuclear palsy: clinico-pathological and biochemical studies.

Authors:  K Jellinger; P Riederer; M Tomonaga
Journal:  J Neural Transm Suppl       Date:  1980

8.  Ocular manifestations in progressive supranuclear palsy.

Authors:  D D Pfaffenbach; D D Layton; T P Kearns
Journal:  Am J Ophthalmol       Date:  1972-12       Impact factor: 5.258

9.  Expression of the histocompatibility glycoprotein HLA-DR in neurological disease.

Authors:  P L McGeer; S Itagaki; E G McGeer
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

10.  Abnormal Tau proteins in progressive supranuclear palsy. Similarities and differences with the neurofibrillary degeneration of the Alzheimer type.

Authors:  S Flament; A Delacourte; M Verny; J J Hauw; F Javoy-Agid
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

View more
  2 in total

1.  Imaging of microglia in patients with neurodegenerative disorders.

Authors:  Marios Politis; Paul Su; Paola Piccini
Journal:  Front Pharmacol       Date:  2012-05-29       Impact factor: 5.810

2.  A single systemic inflammatory insult causes acute motor deficits and accelerates disease progression in a mouse model of human tauopathy.

Authors:  Megan Torvell; David W Hampton; Peter Connick; Alasdair M J MacLullich; Colm Cunningham; Siddharthan Chandran
Journal:  Alzheimers Dement (N Y)       Date:  2019-10-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.